These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8314290)

  • 1. [Parenteral cephalosporins for the treatment of lower respiratory tract infections].
    Vogel F
    Infection; 1993; 21 Suppl 1():S28-34. PubMed ID: 8314290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of community-acquired lower respiratory tract infections with oral cefuroxime axetil.
    Limson BM; Garvez MD
    Clin Ther; 1990; 12(5):436-9. PubMed ID: 2268866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guide to the treatment of lower respiratory tract infections.
    Vogel F
    Drugs; 1995 Jul; 50(1):62-72. PubMed ID: 7588090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
    Bogdanov MB; Chernen'kaia TV
    Antibiot Khimioter; 2000; 45(10):15-8. PubMed ID: 11212394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of cefuroxime in paediatric community-acquired pneumonia.
    Olivier C
    Paediatr Drugs; 2000; 2(5):331-43. PubMed ID: 11022795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of experience with ofloxacin in respiratory tract infection.
    Ball P
    Scand J Infect Dis Suppl; 1990; 68():56-63. PubMed ID: 2218424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefuroxime in severe respiratory infections: a double-blind comparison of two doses.
    Pines A; Raafat H
    Br J Dis Chest; 1979 Oct; 73(4):395-8. PubMed ID: 400110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe lower respiratory tract infections with ceftriaxone (Ro 13-9904). A pilot study.
    Keller R; Humair L
    Chemotherapy; 1981; 27 Suppl 1():93-9. PubMed ID: 7249798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM; Brogden RN
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional specifics of microbial landscape in outpatients with lower respiratory tract infections.
    Baturin VA; Shchetinin EV; Malykhin FT
    Int J Risk Saf Med; 2015; 27 Suppl 1():S61-2. PubMed ID: 26639714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactam antibiotics in lower respiratory tract infections.
    Schreiner A
    Scand J Infect Dis Suppl; 1984; 42():129-34. PubMed ID: 6597558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative trial to evaluate the efficacy and tolerability of cefuroxime 250mg with probenecid 250mg with cefuroxime 500mg in the management of community acquired pneumonia, acute bronchitis and acute exacerbation of chronic bronchitis.
    Rao PP; Mopkar O; Desai A
    J Indian Med Assoc; 2000 Oct; 98(10):650-1, 654. PubMed ID: 11258501
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
    Holloway WJ; Palmer D
    Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with cefuroxime in pediatric field (author's transl)].
    Hotta M; Oikawa T; Sunagawa K; Nanri S; Yamashita N; Akita H; Ichihashi Y
    Jpn J Antibiot; 1979 Nov; 32(11):1161-4. PubMed ID: 513298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
    Vergis EN; Indorf A; File TM; Phillips J; Bates J; Tan J; Sarosi GA; Grayston JT; Summersgill J; YU VL
    Arch Intern Med; 2000 May; 160(9):1294-300. PubMed ID: 10809032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ; Ormrod D; Goa KL
    Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study].
    Schwigon CD; Cuhorst R; Gabor M; Zinndorf J; Springsklee M
    Med Klin (Munich); 1993 Jan; 88(1):16-20. PubMed ID: 8437527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.